Familial antithrombin III deficiency: Its natural history, genetics, diagnosis and treatment

Medicine (United States)

Volumn 62, Issue 4, 1983, Pages 209-220

  Cosgriff, T M ^a   Bishop, D T ^a   Hershgold, E J ^a   Skolnick, M H ^a   Martin, B A ^a   Baty, B J ^a   Carlson, K S ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; HEPARIN; WARFARIN;

AUTOSOMAL DOMINANT INHERITANCE; BLOOD AND HEMOPOIETIC SYSTEM; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; DIAGNOSIS; DRUG THERAPY; GENETICS; HEREDITY; HUMAN; HYPERCOAGULATION; INHERITANCE; THERAPY; THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; ANTITHROMBIN III; ANTITHROMBIN III DEFICIENCY; CHILD; CHILD, PRESCHOOL; DUFFY BLOOD-GROUP SYSTEM; EXTREMITIES; FEMALE; HUMANS; INFANT; LINKAGE (GENETICS); MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; PEDIGREE; PHYSICAL EXAMINATION; PROBABILITY; THROMBOSIS; UTAH;

EID: 0020619944     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/00005792-198307000-00002     Document Type: Article

References (112)

1. Abildgaard U. Highly purified antithrombin III with heparin cofactor activity prepared by disc electrophoresis. Scand J Clin Lab Invest 21:89,1968.
2. Abildgaard U. Purification of two progressive antithrombins of human plasma. Scand J Clin Lab Invest 19:190,1967.
3. Abildgaard U, Odegard OR, Kierulf P, Pepper DS. Influence of platelet factor 4 on inhibited thrombin substrate reactions. Thromb Res 5:185,1974.
4. Abildgaard U. Inhibition of the thrombin-fibrinogen reaction by antithrombin III, studied by N-terminal analysis. Scand J Clin Lab Invest 20:205,1967.
5. Abildgaard U, Gravem K, Godal HC. Assay of progressive antithrombin in plasma. Thromb Diath Haemorrh 24:244,1970.
6. Abildgaard U, Lie M, Ødegard OR. A simple amidolytic method for the determination of functionally active antithrombin III. Scand J Clin Lab Invest 36:109,1976.
7. Abildgaard U, Lie OR, Ødegárd OR. Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chro-mozym TH). Thromb Res 11:549,1977.
8. Abildgaard U, Fagerhol MK, Egeberg O. Comparison of progressive antithrombin activity and the concentrations of three thrombin inhibitors in human plasma. Scand J Clin Lab Invest 26:349,1970.
9. Ambruso DR, Jacobson LJ, Hathaway WE. Inherited antithrombin III deficiency and cerebral thrombosis in a child. Pediatrics 65:125,1980.
10. Astrup T, Darling S. Antithrombin and heparin. Acta Physiol Scand 5:13,1943.
11. Bergsjo P, Fagerhol MK, Abildgaard U. Antithrombin III concentration in women using low-dosage progestagen for contraception. Am J Obstet Gynecol 112:938,1972.
12. Bick RL, Dukes ML, Wilson WL. Antithrombin III (AT-III) as a diagnostic aid in disseminated intravascular coagulation. Thromb Res 10:721,1977.
13. Biggs R, Denson KWE, Akman N, Barrett R, Hadden M. Antithrombin III, antifactor Xa and heparin. Br J Haematol 19:283,1970.
14. Blomback M, Blombaek B, Olsson P, Svendsen L. The assay of antithrombin using a synthetic chromogenic substrate for thrombin. Thromb Res 5:621,1974.
15. Brandt P, Stenbjerg S. Subcutaneous heparin for thrombosis in pregnant women with hereditary antithrombin deficiency. Lancet 1:100, 1979.
16. Brinkhous KM, Smith HP, Warner ED, Seegers WH. The inhibition of blood clotting: An unidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin to thrombin. Am J Physiol 125:683,1939.
17. Brozovic M, Stirling Y, Hamyln AN. Thrombotic tendency and probable antithrombin III deficiency. Thromb Haemostas 39:778,1978.
18. Buonameaux H, Duckert F, Walter M, Buonameaux Y. The determination of antithrombin III. Comparison of six methods. Effect of oral contraceptive therapy. Thromb Haemostas 39:607,1978.
19. Buonassisi V. Sulfated mucopolysaccharide synthesis and secretion in endothelial cell cultures. Exp Cell Res 76:363,1973.
20. Cannings C, Thompson EA, Skoinick MH. Probability functions on complex pedigrees. Adv Appl Prob 10:26,1978.
21. Carvalho A, Euman L. Hereditary antithrombin III deficiency. Effect of antithrombin III deficiency on platelet function. Am J Med 61:179,1976.
22. Collins GJ, Jr, Heymann RL, Zajtchuk R. Hypercoagulability in patients with peripheral vascular disease. Am J Surg 130:2,1975.
23. Contejean C. Recherches sur les injections intraveineusesde peptone et Ieur influence sur la coagulabilité du sang chez Ie chien. Arch Physiol Norm Pathol 7:45,1895.
24. Cosgriff TM, Hodgson LA, West JV. The antithrombin III content of crvoprecipitate prepared from blood collected with and without heparin. Vox Sang 44:98,1982.
25. Damus PS, Wallace GA. Immunologic measurement of antithrombin Ill-heparin cofactor and alpha 2-macroglobulin in disseminated intravascular coagulation and hepatic failure coagulopathy. Thromb Res 6: 27. 1975.
26. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 13:516,1965.
27. Fagerhol MK, Abildgaard U. Immunological studies on human antithrombin III. Influence of age, sex and use of oral contraceptives on serum concentration. Scand J Haematol 7:10,1970.
28. Fiessinger JN, Aiach M. Stanazolol treatment in an AT III deficient patient. Thromb Haemostas 43:183,1980.
29. Filip DJ, Eckstein JD, Veltkamp JJ. Hereditary antithrombin IN deficiency and thromboembolic disease. Am J Hematol 2:343,1976.
30. German J, Chaganti R. Mapping human autosomes: Assignment of the MN locus to a specific segment in the long arm of chromosome No. 2. Science 182:1261,1973.
31. Grannis GF, Kazal LA. Prothrombin and antithrombin: Their opposing functions in blood coagulation. Thromb Diath Haemorrh 13:497,1965.
32. Grieg HBW, Notelowitz M. Natural oestrogens and antithrombin-III levels. Lancet 1:412, 1975.
33. Gruenberg JC, Smallridge RC, Rosenberg RD. Inherited antithrom-bin-III deficiency causing mesenteric venous infarction. A new clinical entity. Ann Surg 181:791,1975.
34. Gurewich V, Lipinski B. Low-dose intravenous heparin in the treatment of disseminated intravascular coagulation. Am J Med Sci 274:83, 1977.
35. Gyde OHB, Middleton MD, Vaughan GR, Fletcher DJ: Antithrombin III deficiency, hypertriglyceridaemia, and venous thromboses. Br Med J 1:621,1978.
36. Harpel PC, Rosenberg RD. a 2-macroglobulin and antithrombin-heparin cofactor: Modulators of hemostatic and inflammatory reactions. Prog Hemostasis Thromb 3:145,1976.
37. Hasstedt SJ, Cartwright PE. PAP: Pedigree Analysis Package. Technical Report 13, Department of Medical Biophysics and Computing, University of Utah, 1978.
38. Hedner U, Nilsson IM. Antithrombin-III in a clinical material. Seventh European Conference on the Microcirculation, Aberdeen, 1972, Part II. Bibl Anat No 12:267,1973.
39. Hensen A, Loeliger EA. Antithrombin III. Its metabolism and its function in blood coagulation. Thromb Diath Haemorrh 9 (Suppl. I): 1, 1963.
40. Howell WH, Holt E. Two new factors in blood coagulation-heparin and pro-antithrombin. Am J Physiol 47:328,1918.
41. Howell WH. The condition of the blood in hemophilia, thrombosis and purpura. Arch Intern Med 13:76,1914.
42. Hule V. Vrozene rodinné snizeni antitrombinu III. Vnit Lek 23:887,1977.
43. Innerfield I, Goldfischer JD, Reicher-Reiss H, Greenberg J. Serum antithrombin in coronary-artery disease. Am J Clin Pathol 65:64,1976.
44. Innerfield I, Stone ML, Mersheimer W, Clauss RD, Greenberg J. Antithrombin and heparin antithrombin patterns in pre-thrombosis and thrombosis. Am J Clin Pathol 65:384,1976.
45. Josso F, Aurousseau MH, Fischer AM, Dautzenberg MD, Beguin S. Hereditary antithrombin III deficiency: Evidence of increased thrombin formation in the early stage of hemostasis. VI International Congress on Thrombosis and Haemostasis, 1976, abstract, p.75.
46. Kauffmann RH, Veltkamp JJ, Van Tilburg NH, Van Es LA. Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med 65:607,1978.
47. Korwald E, Abildgaard U, Fagerhol MK. Major operations, hemostatic parameters and venous thrombosis. Thromb Res 4:147,1974.
48. Laurell C-B. Antigen-antibody crossed electrophoresis. Anal Biochem 10:358,1965.
49. Laurell C-B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15:45,1966.
50. Lechner VK, Thaler E, Niessner H, Nowotny Ch, Partsch H. An-tithrombin-III-Mangel und Thromboseneigung. Wien Klin Woch-enschr 89:215,1977.
51. Leone G, Valori VM, Storti S, Myers TJ. Inferior vena cava thrombosis in a child with familial antithrombin III deficiency. Thrombos Haemostas 43:74,1980.
52. Losito R, Beaudry P, Valderrama JC, Cousineau L, Longpre B. Antithrombin III and Factor VIII in patients with neoplasms. Am J Clin Pathol 68:258,1977.
53. Losonczy H, Nagy I. Effect of heparin in hereditary antithrombin III deficiency (Abstract]. In: Proceedings XI International Congress on Thrombosis and Haemostasis, p 382, 1981.
54. Lovrien EW, Magenis RE, Rivas ML, Goodnight S, Moreland R, Rowe S. Linkage study of antithrombin III. Cytogenet Cell Genet 22:319,1978.
55. Mackie M, Bennett B, Ogston D, Douglas AS. Familial thrombosis: Inherited deficiency of antithrombin III. Br Med J 1:136, 1978.
56. Magenis RE, Donlon T, Parks M, Rivas ML, Lovrien EW. Linkage relationships of dominant antithrombin III deficiency and the heterochromatic region of chromosome I. Cytogenet Cell Genet 22:327,1978.
57. Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunoehem-istry 2:235,1965.
58. Marciniak E, Farley CH, DeSimone PA. Familial thrombosis due to antithrombin deficiency. Blood 43:219,1974.
59. Mareiniak E, Gockerman JP. Heparin-induced decrease in circulating antithrombin-III. Lancet 2:581,1977.
60. Mareiniak E. Adverse effect of heparin in thrombin-antithrombin III interaction. Thromb Diath Haemorrh 34:748,1975.
61. Matsuda T, Ogawara M, Kodama M, Murakami M. Changes of antithrombin (antithrombin III, a-macroglobulin) in various diseases. Acta Haematol Jap 40:261,1977.
62. McKusick VA. Mendelian Inheritance in Man: Catalogs of autosomal dominant, autosomal recessive, and X-Iinked phenotypes. 5th Ed. Baltimore: The Johns Hopkins University Press, p. 32, 1975.
63. Miller-Andersson M, Borg H, Andersson L-O. Purification of antithrombin III by affinity chromatography. Thromb Res 5:439,1974.
64. Mitchell GA, Hudson PM, Huseby RM, Pochron SP, Gargiulo RJ. Fluorescent substrate assay for antithrombin III. Thromb Res 12:219,1978.
65. Monkhouse FC, France ES, Seegers WH. Studies on the antithrombin and heparin cofactor activities of a fraction adsorbed from plasma by aluminum hydroxide. Circ Res 3:397,1955.
66. Morawitz P. Die Chemie der Blutgerinnung. Ergeb Physiol 4:307,1905.
67. Nakagawa M, Okajima Y, Kitani T, Watada M, Yoshikawa H, Hino R, Ijichi H. Localization of antithrombin III on the vascular endothelium and its function [Abstract]. In: Proceedings XI International Congress of Thrombosis and Haemostasis, p 73, 1981.
68. Nesje OA, Kordt KF. Hypoantithrombinemi som arsak til mesen-terialvenetrombose. Nord Med 83:367,1974.
69. O'Brien JR. Antithrombin III and heparin clotting times in thrombosis and atherosclerosis. Thromb Diath Haemorrh 32:116,1974.
70. Ødegård OR, Abildgaard U. Antifactor Xa activity in thrombophilia. Studies in a family with AT-III deficiency. Scand J Haematol 18:86, 1977.
71. Ødegård OR, Fagerhol MK, Lie M. Heparin cofactor activity and antithrombin III concentration in plasma related to age and sex. Scand J Haematol 17:258,1976.
72. Ødegård OR, Lie M, Abildgaard U. Heparin cofactor activity measured with an amidolytic method. Thromb Res 6:287,1975.
73. Ødegård OR, Abildgaard U. Antithrombin III: Critical review of assay methods. Significance of variations in health and disease. Haemostasis 7:127,1978.
74. Ogura H, Miyaji K, Kinoshita T, Aoki N. The change of antithrombin III activity of pregnant women and women on oral contraceptives. Acta Haematol Jap 40:232,1977.
75. Oguri T, Kato R, Sugawara Y, Sugie I, Yamamoto H. Changes of antithrombin III in the thrombotic diathesis. Acta Haematol Jap 40:244,1977.
76. Penner JA, Hunter MJ. Antithrombins: Clinical aspects, chemical and biological properties. Prog Clin Biol Res 5:277,1976.
77. Peterson RA, Krull PE, Finley P, Ettinger MG: Changes in antithrombin IN and plasminogen induced by oral contraceptives. Am J Clin Pathol 53:468,1970.
78. Pitney WR, Manoharan A, Dean S. Antithrombin III deficiency in an Australian family. Br J Haematol 46:147,1980.
79. Quick AJ. The normal antithrombin of the blood and its relation to heparin. Am J Physiol 123:712,1938.
80. Reuter NF. Heparin insensitivity responding to fresh frozen plasma. Minn Med 61:79,1978.
81. Rey JL, Delobel J, Claisse JF, Quiret JC, Bor P, Bernasconi P. Embolie pulmonaire severe et thrombophlébite recidivante en rapport avec un deficit hereditaire en antithrombine III. Arch Mal Coeur 72:919,1979.
82. Ririe DG, Cosgriff TM, Martin BS. Central retinal vein occlusion in a patient with familial antithrombin III deficiency: Case report. Ann Ophthalmol 11:1841,1979.
83. Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 248:6490,1973.
84. Rosenberg RD. Actions and interactions of antithrombin and heparin. N Engl J Med 292:146,1975.
85. Sagar S, Thomas DP, Stamatakis JD Kakkar VV. Oral contraceptives, antithrombin-III activity, and postoperative deep-vein thrombosis. Lancet 1:509, 1976.
86. Sas G, Blasko D, Banhegyi D, Jako J, Palos LA. Abnormal antithrombin III (antithrombin III "Budapest") as a cause of a familial thrombophilia. Thromb Diath Haemorrh 32:105,1974.
87. Sas G, Pepper DS, Cash JD. Further investigations of antithrombin IN in the plasmas of patients with the abnormality of "antithrombin III Budapest." Thromb Diath Haemorrh 33:564,1975.
88. Sas G, Koves A, Peto I, Domjan G. On the inheritance of the abnormal antithrombin NI ("AT-III Budapest"). Thromb Haemos-tas 39:530,1978.
89. Schipper HG, Kahle LH, Jenkins CSP, ten Cate JW. Antithrombin-III transfusion in disseminated intravascular coagulation. Lancet 1:854, 1978.
90. Shapiro SS, Prager D, Martinez J. Inherited antithrombin III deficiency associated with multiple thromboembolic phenomena [Abstract]. Blood 42:1001,1973.
91. Shapiro SS, Anderson DB. Thrombin inhibition in normal plasma. In Chemistry and biology of thrombin. Lundblad RL, Fenton JW II, Mann KG, eds. Ann Arbor, Mich: Ann Arbor Science Publishers, Inc., pp. 361-374, 1977.
92. Stathakis NE, Papayannis AG, Antonopoulos M, Gardikas C. Familial thrombosis due to antithrombin NI deficiency in a Greek family. Acta Haematol 57:47,1977.
93. Takamatsu S, Satoh K, Sakuta S, Mizuno S, Sugawara H, Murakami S. Plasma and serum antithrombin NI levels in cerebrovascular patients. Acta Haematol Jap 40:238,1977.
94. Teger-Nilsson A-C. Antithrombin in infancy and childhood. Acta Paediatr Scand 64:624,1975.
95. Thaler E, Niessner H, Kleinberger G, Gassner A. Antithrombin III replacement therapy in patients with congenital and acquired antithrombin III deficiency [Abstract]. In: Proc VII International Congress on Thrombosis and Haemostasis, p 327, 1979.
96. Thompson E, Cannings C. Sampling schemes and ascertainment. In Genetic analysis of common disease: Applications to predictive factors in coronary disease. New York: Alan R. Liss, Inc., p 363-382,1979.
97. Thuot C, Marion D, Boucher H. Deficit congenital en antithrombine III: Étude d'une famille québefoise. Union Med Can 106:673,1977.
98. Ur A. Fatal embolism despite heparin treatment. Lancet 1: 959,1976.
99. Van der Meer J, Stoepman-Van Dalen EA, Jansen JMS. Antithrom-bin-III deficiency in a Dutch family. J Clin Pathol 26:532,1973.
100. Villaneuva GB, Danishefsky I. Evidence for a heparin-induced conformation change in antithrombin NI. Biochem Biophys Res Com-mun 74:803,1977.
101. Vinazzer H. Photometric assay of antithrombin NI with a chromo-genic substrate. Haemostasis 4:101,1975.
102. von Kaulla E, von Kaulla KN. Deficiency of antithrombin III activity associated with hereditary thrombosis tendency. J Med 3:349,1972.
103. von Kaulla E, von Kaulla KN. Antithrombin NI and diseases. Am J Clin Pathol 48:69,1967.
104. von Kaulla E, von Kaulla KN. Oral contraceptives and low antith-rombin-III activity. Lancet 1: 36,1970.
105. von Kaulla E, Droegemueller W, Aoki N, von Kaulla KN. Antithrombin III depression and thrombin generation acceleration in women taking oral contraceptives. Am J Obstet Gynecol 109:868,1971.
106. Waugh DF, Fitzgerald MA. Quantitative aspects of antithrombin and heparin in plasma. Am J Physiol 184:627,1956.
107. Williams L, Murano G. Human antithrombin III heterogeneity. Blood 57:229,1981.
108. Winter J, Bennett B, Watt J, Brown T, San Roman C, Schinzel A, King J, Cook, P. Confirmation of linkage between antithrombin NI and Duffy blood group and assignment of AT 3 to Iq22-q25. Ann Hum Genet 46:29,1982.
109. Yamaguehi T, Konishi M, Kuto M, Shima H, Kato F, Umemoto H, Kaneko D, Beppu H, Kusunose K, Deguchi K, Izuchi Y, Yamada S. Studies on serum AT IN levels in various diseases. Acta Haematol Jap 40:255,1977.
110. Yin ET, Wessler S, Stoll PJ. Biological properties of the naturally occurring plasma inhibitor to activated factor X. J Biol Chem 246:3703,1971.
111. Zuck TF, Bergin JJ, Raymond JM, Dwyre WR. Implications of depressed antithrombin-III activity associated with oral contraceptives. Surg Gynecol Obstet 133:609,1971.
112. Zucker ML, Gomperts ED, Marcus RG. Prophylactic and therapeutic use of anticoagulants in inherited antithrombin III deficiency. S Afr Med J 50:1743,1976.